SRPT
Sarepta Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.73
+3.68%Forward multiples
Based on analyst estimates
- P/E forward
- 49.14x
- P/E 2026E
- 5.62x
- P/E 2027E
- 34.73x
- P/E 2028E
- 80.41x
- P/S forward
- 1.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.23x
- Price / sales
- 0.95x
- Price / cash flow
- -20.43x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 1.08x
- EV / EBITDA
- -146.06x
- EV / EBIT
- -14.87x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026